Related Experiment Video
Updated: Feb 11, 2026
Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
Published on: August 30, 2011
[11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy
Luca Passamonti1, Patricia Vázquez Rodríguez2, Young T Hong2
1From the Departments of Clinical Neurosciences (L.P., P.V.R., Y.T.H., P.S.J., R.J.B., T.D.F., F.I.A., J.B.R.) and Psychiatry (W.R.B.-J., R.A., A.S., E.M., L.S., J.T.O.), University of Cambridge, UK; Istituto di Bioimmagini e Fisiologia Molecolare (L.P.), Consiglio Nazionale delle Ricerche, Milano, Italy; Wolfson Brain Imaging Centre (Y.T.H., D.W., T.D.F., F.I.A.), University of Cambridge; Department of Histopathology (K.S.J.A.), Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; China-UK Centre for Cognition and Ageing Research (L.S.), Southwest University, Chongqing, China; and Medical Research Council Cognition and Brain Sciences Unit (J.B.R.), UK. lp337@medschl.cam.ac.uk.
Objective:
We tested whether in vivo neuroinflammation relates to the distinctive distributions of pathology in Alzheimer disease (AD) and progressive supranuclear palsy (PSP).
Methods:
Sixteen patients with symptomatic AD (including amnestic mild cognitive impairment with amyloid-positive PET scan), 16 patients with PSP-Richardson syndrome, and 13 age-, sex-, and education-matched healthy controls were included in this case-control study. Participants underwent [11C]PK11195 PET scanning, which was used as an in vivo index of neuroinflammation.
Results:
[11C]PK11195 binding in the medial temporal lobe and occipital, temporal, and parietal cortices was increased in patients with AD, relative both to patients with PSP and to controls. Compared to controls, patients with PSP showed elevated [11C]PK11195 binding in the thalamus, putamen, and pallidum. [11C]PK11195 binding in the cuneus/precuneus correlated with episodic memory impairment in AD, while [11C]PK11195 binding in the pallidum, midbrain, and pons correlated with disease severity in PSP.
Conclusions:
Together, our results suggest that neuroinflammation has an important pathogenic role in the 2 very different human neurodegenerative disorders of AD and PSP. The increase and distribution of microglial activation suggest that immunotherapeutic strategies may be useful in slowing the progression of both diseases.
More Related Videos
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Related Concept Videos
01:22Alzheimer's Disease: Treatment
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
02:18The Equilibrium Binding Constant and Binding Strength
02:18The Equilibrium Binding Constant and Binding Strength
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:40Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...